Return to search

Legend racks up $150.5m Series A

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, has raised $150.5 million in Series A financing.

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, has raised $150.5 million in Series A financing. The investors included Hudson Bay Capital Management LP, Johnson & Johnson Innovation – JJDC Inc., Lilly Asia Ventures, Vivo Capital and RA Capital Management. Morgan Stanley Asia Limited and Jefferies Hong Kong Limited advised Legend in this transaction.

Source: Press Release